Ultragenyx Pharmaceutical
RARE
$52.48
Share price
-1.97%
Change (1 day)
-31.25%
Change (1 year)
Categories
Ultragenyx Pharmaceutical (RARE) - Total debt
Total debt on the balance sheet as of December 2024 : A$66.58 Million
According to Ultragenyx Pharmaceutical's latest financial reports the company's total debt is A$66.58 Million. A company’s total debt is the sum of all current and non-current debts.
Ultragenyx Pharmaceutical - Total debt on balance sheet (from 2018 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | A$64.85 M | 2.35% |
| 2023-12-31 | A$63.36 M | 36.48% |
| 2022-12-31 | A$46.42 M | -19.8% |
| 2021-12-31 | A$57.89 M | -7.7% |
| 2020-12-31 | A$62.71 M | 18.71% |
| 2019-12-31 | A$52.83 M | |
| 2018-12-31 | N/A |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | A$0.99 B | 1,394.12% | 🇺🇸 USA |
 | A$0.73 B | 999.79% | 🇺🇸 USA |
 | A$0.49 B | 637.75% | 🇺🇸 USA |
 | A$0.17 B | 168.72% | 🇺🇸 USA |